Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 10.29
+0.03 (0.29%)
May 19, 2026, 10:25 AM CST
SHE:300463 Revenue
Maccura Biotechnology Co.Ltd had revenue of 475.26M CNY in the quarter ending March 31, 2026, a decrease of -6.86%. This brings the company's revenue in the last twelve months to 2.14B, down -12.58% year-over-year. In the year 2025, Maccura Biotechnology Co.Ltd had annual revenue of 2.17B, down -14.84%.
Revenue (ttm)
2.14B
Revenue Growth
-12.58%
P/S Ratio
2.91
Revenue / Employee
615.05K
Employees
3,106
Market Cap
6.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.17B | -378.29M | -14.84% |
| Dec 31, 2024 | 2.55B | -347.01M | -11.98% |
| Dec 31, 2023 | 2.90B | -712.64M | -19.75% |
| Jan 1, 2023 | 3.61B | -372.24M | -9.35% |
| Jan 1, 2022 | 3.98B | 276.77M | 7.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.98B |
| Shanghai Runda Medical Technology | 6.85B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.19B |
| Thalys Medical Technology Group | 971.32M |
| Berry Genomics Co.,Ltd | 922.27M |